Press release

Nutanix Announces Updates to its Board of Directors

New Board Member Eric K. Brandt Brings Extensive Leadership and Finance Experience to Nutanix Board David Humphrey Resigns from Nutanix Board SAN JOSE,

articleNutanix, Inc.May 16, 20254/company/nutanix-inc/news/nutanix-announces-updates-its-board-directors-2025-05-16
Nutanix Announces Updates to its Board of Directors

About this update from Nutanix, Inc.

[{"type":"text","content":"New Board Member Eric K. Brandt Brings Extensive Leadership and Finance Experience to Nutanix Board David Humphrey Resigns from Nutanix Board SAN JOSE, Calif., May 16, 2025 (GLOBE NEWSWIRE) -- Nutanix (NASDAQ: NTNX), a leader in hybrid multicloud computing, announced today that it has added Eric K. Brandt to its board of directors, effective May 15, 2025. “Eric brings deep expertise in both CEO and CFO roles across a variety of industries. His long-term service on boards of public companies also gives him a richness of experience from which Nutanix is sure to benefit,” said Virginia Gambale, Chair of the Board at Nutanix. “I look forward to serving with him together on the Nutanix board as the company continues to focus on driving sustainable, profitable growth while providing customers with a single platform for running applications and managing data, anywhere.” Brandt is a seasoned executive and board director with more than 30 years of global experience spanning finance, operations, and corporate governance. He served as Chief Financial Officer of Broadcom Corporation from 2007 until it was acquired by Avago Technologies Limited in 2016, where he played a pivotal role in the company’s growth into one of the world’s largest semiconductor firms. Prior to that, he held senior executive positions, including President and CEO of Avanir Pharmaceuticals, Inc. and Chief Financial Officer of Allergan, Inc. Brandt currently serves on the boards of Gen Digital Inc., Lam Research Corporation, The Macerich Company, and Option Care Health, Inc. He previously served on the boards of Altaba Inc. and DENTSPLY SIRONA Inc., among others. He holds a B.S. in Chemical Engineering from the Massachusetts Institute of Technology and an M.B.A. from Harvard Business School. Additionally, David Humphrey resigned from Nutanix’s board of directors, effective May 15, 2025. Humphrey, a Partner at Bain Capital, joined the Nutanix Board as part of Bain Capital’s $750 million investment in September 2020. Following Humphrey’s resignation, Max de Groen, another Partner at Bain Capital, will continue to serve as a member of Nutanix’s board of directors. “We thank David for the constructive engagement, guidance and expertise that he brought to the board during a period of significant transformation and growth for Nutanix,” said Gambale. “We are grateful for his v...

More updates from Nutanix, Inc.